Levodopa;Carbidopa shortage status
1 active shortage notice across 1 country.
Last updated 1 Nov 2026 · sourced from official medicines regulators
- Generic name (INN)
- Levodopa;Carbidopa
- Brand names
- Numient
- Class
- Auto-created by EMA — Withdrawn / Refused / Revoked Medicines scraper
Where Levodopa;Carbidopa is in shortage
Why Levodopa;Carbidopa is in shortage
- supply-chain disruption — e.g. “Export restricted due to shortage” (Portugal)
Recent shortage history
- Colombia: resolved 4 Jul 2026 (began 5 Sept 2022)
- Colombia: resolved 22 Aug 2026 (began 9 May 2022)
Frequently asked questions
Is Levodopa;Carbidopa currently in shortage?
Yes. As of the latest regulator updates, Levodopa;Carbidopa has 1 active shortage notice across 1 country (Portugal). Status is refreshed daily from official regulatory sources.
Why is Levodopa;Carbidopa in shortage?
Regulators attribute the current Levodopa;Carbidopa shortages to supply-chain disruption. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Levodopa;Carbidopa shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Get alerted when Levodopa;Carbidopa status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.